GDRX Investors Have Opportunity to Lead GoodRx Holdings, Inc. Securities Fraud Lawsuit

16.06.24 16:15 Uhr

Werte in diesem Artikel

NEW YORK, June 16, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 and November 8, 2022. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by June 21, 2024.

Rosen Law Firm, P.A. Logo

For more information, and to join the GoodRx class action, go to https://rosenlegal.com/submit-form/?case_id=24355mailto:or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com.

The Rosen Law Firm is investigating allegations that GoodRx Holdings, Inc. (GDRX) misled investors regarding its business operations.

According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: (1) while Kroger accounted for less than 5% of the pharmacies accepting GoodRx discounts, Kroger was responsible for nearly 25% of GoodRx's total prescription transactions revenue (the Company's primary revenue stream); and (2) Kroger could unilaterally cease accepting GoodRx discounts, cutting off some or all of GoodRx's revenues for purchases at Kroger's pharmacies; and (3) as a result, defendants' representations about GoodRx's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

What Now: You may be eligible to participate in the class action against GoodRx Holdings, Inc. The deadline to file a motion to be appointed as lead plaintiff is June 21, 2024. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, go to https://rosenlegal.com/submit-form/?case_id=24355.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      case@rosenlegal.com
      www.rosenlegal.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/gdrx-investors-have-opportunity-to-lead-goodrx-holdings-inc-securities-fraud-lawsuit-302173388.html

SOURCE THE ROSEN LAW FIRM, P. A.

Ausgewählte Hebelprodukte auf GoodRx A

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf GoodRx A

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu GoodRx Holdings Inc Registered Shs -A-